Ilex Medical Ltd (TLV:ILX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 5,457.00
-72.00 (-1.30%)
Apr 29, 2026, 4:04 PM IDT
Ilex Medical Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 55.56 | 38.98 | 50.89 | 102.12 | 197.48 | Upgrade
|
| Depreciation & Amortization | 47.61 | 47.44 | 47.72 | 50.04 | 50.49 | Upgrade
|
| Other Amortization | 1.9 | 1.66 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | 0.46 | -0.26 | -21.96 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.74 | -3.47 | -4.12 | 2.84 | -3.68 | Upgrade
|
| Loss (Gain) on Equity Investments | 10.63 | 7.19 | 4.01 | 2.69 | 0.26 | Upgrade
|
| Other Operating Activities | 14.85 | 12.51 | -10.89 | -24.42 | 25.16 | Upgrade
|
| Change in Accounts Receivable | -17.9 | 32.14 | -56 | -23.9 | 21.28 | Upgrade
|
| Change in Inventory | -35.27 | -0.22 | -14.13 | -27.71 | 20.89 | Upgrade
|
| Change in Accounts Payable | 21.6 | -43.96 | 32.49 | 10.6 | -20.22 | Upgrade
|
| Change in Unearned Revenue | -64.51 | 3.77 | 96.58 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 45.27 | -8.16 | -61.21 | 5.79 | -21 | Upgrade
|
| Operating Cash Flow | 72.87 | 81.63 | 80.43 | 69.74 | 270.68 | Upgrade
|
| Operating Cash Flow Growth | -10.73% | 1.49% | 15.33% | -74.23% | 48.39% | Upgrade
|
| Capital Expenditures | -26.98 | -29.76 | -48.77 | -26.14 | -40.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.15 | 0.28 | 0.17 | 0.08 | 1.06 | Upgrade
|
| Cash Acquisitions | - | - | - | -10.51 | - | Upgrade
|
| Divestitures | - | 1.94 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -3.08 | -3.58 | -3.39 | -2.22 | -1.7 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | - | 43 | - | Upgrade
|
| Investment in Securities | -16.74 | 8.18 | -38.68 | -50.78 | -38.1 | Upgrade
|
| Other Investing Activities | - | - | - | -7.07 | -2.78 | Upgrade
|
| Investing Cash Flow | -46.65 | -22.94 | -90.68 | -53.64 | -82.45 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.22 | Upgrade
|
| Long-Term Debt Repaid | -13.68 | -13.63 | -13.56 | -13.71 | -26.56 | Upgrade
|
| Total Debt Repaid | -13.68 | -13.63 | -13.56 | -13.71 | -26.77 | Upgrade
|
| Net Debt Issued (Repaid) | -13.68 | -13.63 | -13.56 | -13.71 | -26.77 | Upgrade
|
| Repurchase of Common Stock | - | - | -5.72 | -3.49 | - | Upgrade
|
| Common Dividends Paid | -13.64 | -15.27 | -21.44 | -60 | -60 | Upgrade
|
| Other Financing Activities | - | - | - | -0.1 | -0.01 | Upgrade
|
| Financing Cash Flow | -27.33 | -28.89 | -40.72 | -77.3 | -86.78 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.55 | -0.93 | -1.61 | 2.92 | -2.04 | Upgrade
|
| Net Cash Flow | -1.66 | 28.87 | -52.57 | -58.28 | 99.41 | Upgrade
|
| Free Cash Flow | 45.89 | 51.87 | 31.66 | 43.6 | 229.73 | Upgrade
|
| Free Cash Flow Growth | -11.53% | 63.83% | -27.38% | -81.02% | 66.35% | Upgrade
|
| Free Cash Flow Margin | 4.93% | 5.64% | 3.46% | 5.05% | 21.65% | Upgrade
|
| Free Cash Flow Per Share | 4.10 | 4.64 | 2.83 | 3.87 | 20.36 | Upgrade
|
| Cash Interest Paid | 2.48 | 2.35 | 1.8 | 1.61 | 1.93 | Upgrade
|
| Cash Income Tax Paid | 3.75 | 14.04 | 34.31 | 76.77 | 30.79 | Upgrade
|
| Levered Free Cash Flow | 32.36 | 29.52 | 36.69 | 35.97 | 168.57 | Upgrade
|
| Unlevered Free Cash Flow | 33.65 | 30.98 | 37.8 | 36.95 | 169.8 | Upgrade
|
| Change in Working Capital | -50.81 | -16.43 | -2.28 | -35.22 | 0.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.